-+ 0.00%
-+ 0.00%
-+ 0.00%
Fziomed Receives FDA Clearance for Dynavisc Tendon Protector
Share
Listen to the news
Fziomed Receives FDA Clearance for Dynavisc Tendon Protector
  • Fziomed received FDA 510(k) clearance for its Dynavisc Tendon Protector, expanding its U.S. surgical biomaterials portfolio.
  • The absorbable gel protects tissues following tendon repair by creating a temporary physical barrier during healing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fziomed Inc. published the original content used to generate this news brief on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending